CN108094404A - 一种改进的间充质干细胞保护液及其用途 - Google Patents
一种改进的间充质干细胞保护液及其用途 Download PDFInfo
- Publication number
- CN108094404A CN108094404A CN201711386123.3A CN201711386123A CN108094404A CN 108094404 A CN108094404 A CN 108094404A CN 201711386123 A CN201711386123 A CN 201711386123A CN 108094404 A CN108094404 A CN 108094404A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- cell
- improved
- protection solution
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 52
- 230000001413 cellular effect Effects 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 239000003223 protective agent Substances 0.000 claims abstract description 18
- 230000035699 permeability Effects 0.000 claims abstract description 17
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 17
- 230000035790 physiological processes and functions Effects 0.000 claims abstract description 16
- 239000003112 inhibitor Substances 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 44
- 239000007788 liquid Substances 0.000 claims description 34
- 235000014066 European mistletoe Nutrition 0.000 claims description 17
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims description 17
- 241000221012 Viscum Species 0.000 claims description 17
- 239000004615 ingredient Substances 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 108010074605 gamma-Globulins Proteins 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 claims description 8
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 8
- 108010053481 Antifreeze Proteins Proteins 0.000 claims description 8
- 108010016076 Octreotide Proteins 0.000 claims description 8
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 8
- YJQCOFNZVFGCAF-UHFFFAOYSA-N Tunicamycin II Natural products O1C(CC(O)C2C(C(O)C(O2)N2C(NC(=O)C=C2)=O)O)C(O)C(O)C(NC(=O)C=CCCCCCCCCC(C)C)C1OC1OC(CO)C(O)C(O)C1NC(C)=O YJQCOFNZVFGCAF-UHFFFAOYSA-N 0.000 claims description 8
- 229960002700 octreotide Drugs 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000001540 sodium lactate Substances 0.000 claims description 8
- 229940005581 sodium lactate Drugs 0.000 claims description 8
- 235000011088 sodium lactate Nutrition 0.000 claims description 8
- ZHSGGJXRNHWHRS-VIDYELAYSA-N tunicamycin Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](O)[C@@H](CC(O)[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C(NC(=O)C=C2)=O)O)O1)O)NC(=O)/C=C/CC(C)C)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O ZHSGGJXRNHWHRS-VIDYELAYSA-N 0.000 claims description 8
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241001672694 Citrus reticulata Species 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 235000019441 ethanol Nutrition 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 7
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 5
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 5
- 238000005215 recombination Methods 0.000 claims description 5
- 230000006798 recombination Effects 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- SDZRWUKZFQQKKV-JHADDHBZSA-N cytochalasin D Chemical compound C([C@H]1[C@@H]2[C@@H](C([C@@H](O)[C@H]\3[C@]2([C@@H](/C=C/[C@@](C)(O)C(=O)[C@@H](C)C/C=C/3)OC(C)=O)C(=O)N1)=C)C)C1=CC=CC=C1 SDZRWUKZFQQKKV-JHADDHBZSA-N 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 125000005909 ethyl alcohol group Chemical group 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000002137 ultrasound extraction Methods 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 102000003505 Myosin Human genes 0.000 claims description 2
- 108060008487 Myosin Proteins 0.000 claims description 2
- KYRVNWMVYQXFEU-UHFFFAOYSA-N Nocodazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=CS1 KYRVNWMVYQXFEU-UHFFFAOYSA-N 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 229960000684 cytarabine Drugs 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229950006344 nocodazole Drugs 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 51
- 239000000243 solution Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 12
- 230000004083 survival effect Effects 0.000 abstract description 8
- 230000003834 intracellular effect Effects 0.000 abstract description 6
- 230000005779 cell damage Effects 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- JKOQGQFVAUAYPM-UHFFFAOYSA-N amifostine Chemical compound NCCCNCCSP(O)(O)=O JKOQGQFVAUAYPM-UHFFFAOYSA-N 0.000 abstract description 3
- 229960001097 amifostine Drugs 0.000 abstract description 3
- 239000007864 aqueous solution Substances 0.000 abstract description 3
- 230000009028 cell transition Effects 0.000 abstract description 3
- 230000018044 dehydration Effects 0.000 abstract description 3
- 238000006297 dehydration reaction Methods 0.000 abstract description 3
- 239000003792 electrolyte Substances 0.000 abstract description 3
- 238000007710 freezing Methods 0.000 abstract description 3
- 230000008014 freezing Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000001473 noxious effect Effects 0.000 abstract description 3
- 230000001766 physiological effect Effects 0.000 abstract description 3
- 230000035755 proliferation Effects 0.000 abstract description 3
- 230000001681 protective effect Effects 0.000 abstract description 3
- 230000005855 radiation Effects 0.000 abstract description 3
- 230000006965 reversible inhibition Effects 0.000 abstract description 3
- 238000001228 spectrum Methods 0.000 abstract description 3
- 238000009825 accumulation Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000004321 preservation Methods 0.000 description 6
- 235000013930 proline Nutrition 0.000 description 6
- 239000011521 glass Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000005138 cryopreservation Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000002633 protecting effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000004072 osteoblast differentiation Effects 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 102100022464 5'-nucleotidase Human genes 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- -1 CD31 Proteins 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 230000010190 G1 phase Effects 0.000 description 1
- 102000006354 HLA-DR Antigens Human genes 0.000 description 1
- 108010058597 HLA-DR Antigens Proteins 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
- 101001105486 Homo sapiens Proteasome subunit alpha type-7 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
- 102100025304 Integrin beta-1 Human genes 0.000 description 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 101710160107 Outer membrane protein A Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
- 102100021201 Proteasome subunit alpha type-7 Human genes 0.000 description 1
- 241001480055 Quercus mongolica Species 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002293 adipogenic effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 1
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711386123.3A CN108094404B (zh) | 2017-12-20 | 2017-12-20 | 一种改进的间充质干细胞保护液及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711386123.3A CN108094404B (zh) | 2017-12-20 | 2017-12-20 | 一种改进的间充质干细胞保护液及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108094404A true CN108094404A (zh) | 2018-06-01 |
CN108094404B CN108094404B (zh) | 2021-01-15 |
Family
ID=62211439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711386123.3A Active CN108094404B (zh) | 2017-12-20 | 2017-12-20 | 一种改进的间充质干细胞保护液及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108094404B (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108753730A (zh) * | 2018-06-21 | 2018-11-06 | 南通禄亿生生物科技有限公司 | 一种ntf4基因修饰的脐带间充质干细胞及其构建方法和应用 |
CN108902129A (zh) * | 2018-06-26 | 2018-11-30 | 吉林省太阳鸟再生医学工程有限责任公司 | 细胞冻存组合物及其应用 |
CN109042625A (zh) * | 2018-08-01 | 2018-12-21 | 广州润虹医药科技股份有限公司 | 一种冻存液及其在脐带间充质干细胞冻存中的应用 |
CN109832261A (zh) * | 2019-04-15 | 2019-06-04 | 无锡芯超生物科技有限公司 | 一种细胞冻存液及其应用 |
CN109971702A (zh) * | 2019-03-29 | 2019-07-05 | 北京昱龙摩尔国际生物医学研究院 | 一种人子宫颈上皮细胞分离与培养方法 |
CN110669729A (zh) * | 2019-11-11 | 2020-01-10 | 广东国科细胞科技有限公司 | 一种制备间充质干细胞外泌体的方法 |
CN110810397A (zh) * | 2018-08-09 | 2020-02-21 | 湖北省生命源干细胞有限公司 | 一种造血干细胞冻存液及其制备方法和使用方法 |
CN111662867A (zh) * | 2020-06-30 | 2020-09-15 | 北京昱龙摩尔国际生物医学研究院 | 一种人牙髓细胞分离培养方法 |
CN113913377A (zh) * | 2021-12-09 | 2022-01-11 | 兰州大学 | 一种可提高人间充质干细胞成骨分化效率的培养基及培养方法 |
CN113973805A (zh) * | 2021-10-25 | 2022-01-28 | 北京京蒙细胞生物科技股份有限公司 | 细胞冻存试剂盒及其使用方法 |
CN114600869A (zh) * | 2022-03-14 | 2022-06-10 | 北京益华生物科技有限公司 | 一种细胞运输保存液及其应用 |
CN117859736A (zh) * | 2024-03-12 | 2024-04-12 | 安宁市中医医院 | 一种用于毛囊保存的存储液及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140041249A (ko) * | 2012-09-27 | 2014-04-04 | (주)세포바이오 | 식물 유래의 재조합 인간 혈청 알부민, 지질 및 식물 단백질 가수분해물을 유효성분으로 포함하는 줄기세포 또는 일차배양세포의 동결보존용 조성물 |
CN105325402A (zh) * | 2015-11-13 | 2016-02-17 | 黄林海 | 一种用于玻璃化冻存骨髓间充质干细胞的冻存保护剂 |
CN105394028A (zh) * | 2015-11-16 | 2016-03-16 | 黄林海 | 一种低冷冻损伤的脐带血干细胞冻存方法 |
CN105394027A (zh) * | 2016-01-18 | 2016-03-16 | 黄林海 | 一种低冷冻损伤的骨髓间充质干细胞冻存方法 |
-
2017
- 2017-12-20 CN CN201711386123.3A patent/CN108094404B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140041249A (ko) * | 2012-09-27 | 2014-04-04 | (주)세포바이오 | 식물 유래의 재조합 인간 혈청 알부민, 지질 및 식물 단백질 가수분해물을 유효성분으로 포함하는 줄기세포 또는 일차배양세포의 동결보존용 조성물 |
CN105325402A (zh) * | 2015-11-13 | 2016-02-17 | 黄林海 | 一种用于玻璃化冻存骨髓间充质干细胞的冻存保护剂 |
CN105394028A (zh) * | 2015-11-16 | 2016-03-16 | 黄林海 | 一种低冷冻损伤的脐带血干细胞冻存方法 |
CN105394027A (zh) * | 2016-01-18 | 2016-03-16 | 黄林海 | 一种低冷冻损伤的骨髓间充质干细胞冻存方法 |
Non-Patent Citations (4)
Title |
---|
刘福强等主编: "《医师案头用药参考》", 31 March 2012, 中国中医药出版社 * |
娄峰: "OPC-柑浓素抗病营养技术在肉鸡养殖中的应用", 《现代畜牧兽医》 * |
孔增科等主编: "《易混淆中药品种辨析与临床应用》", 30 June 2007, 天津科技翻译出版公司 * |
师海波等主编: "《最新临床药物手册》", 31 October 2016, 辽宁科学技术出版社 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108753730A (zh) * | 2018-06-21 | 2018-11-06 | 南通禄亿生生物科技有限公司 | 一种ntf4基因修饰的脐带间充质干细胞及其构建方法和应用 |
CN108902129A (zh) * | 2018-06-26 | 2018-11-30 | 吉林省太阳鸟再生医学工程有限责任公司 | 细胞冻存组合物及其应用 |
CN109042625A (zh) * | 2018-08-01 | 2018-12-21 | 广州润虹医药科技股份有限公司 | 一种冻存液及其在脐带间充质干细胞冻存中的应用 |
CN110810397A (zh) * | 2018-08-09 | 2020-02-21 | 湖北省生命源干细胞有限公司 | 一种造血干细胞冻存液及其制备方法和使用方法 |
CN109971702A (zh) * | 2019-03-29 | 2019-07-05 | 北京昱龙摩尔国际生物医学研究院 | 一种人子宫颈上皮细胞分离与培养方法 |
CN109832261A (zh) * | 2019-04-15 | 2019-06-04 | 无锡芯超生物科技有限公司 | 一种细胞冻存液及其应用 |
CN110669729A (zh) * | 2019-11-11 | 2020-01-10 | 广东国科细胞科技有限公司 | 一种制备间充质干细胞外泌体的方法 |
CN110669729B (zh) * | 2019-11-11 | 2021-09-07 | 广州赛莱拉干细胞科技股份有限公司 | 一种制备间充质干细胞外泌体的方法 |
CN111662867A (zh) * | 2020-06-30 | 2020-09-15 | 北京昱龙摩尔国际生物医学研究院 | 一种人牙髓细胞分离培养方法 |
CN113973805A (zh) * | 2021-10-25 | 2022-01-28 | 北京京蒙细胞生物科技股份有限公司 | 细胞冻存试剂盒及其使用方法 |
CN113913377A (zh) * | 2021-12-09 | 2022-01-11 | 兰州大学 | 一种可提高人间充质干细胞成骨分化效率的培养基及培养方法 |
CN113913377B (zh) * | 2021-12-09 | 2024-04-19 | 兰州大学 | 一种可提高人间充质干细胞成骨分化效率的培养基及培养方法 |
CN114600869A (zh) * | 2022-03-14 | 2022-06-10 | 北京益华生物科技有限公司 | 一种细胞运输保存液及其应用 |
CN117859736A (zh) * | 2024-03-12 | 2024-04-12 | 安宁市中医医院 | 一种用于毛囊保存的存储液及其制备方法 |
CN117859736B (zh) * | 2024-03-12 | 2024-05-31 | 安宁市中医医院 | 一种用于毛囊保存的存储液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108094404B (zh) | 2021-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108094404A (zh) | 一种改进的间充质干细胞保护液及其用途 | |
CN106538512B (zh) | 一种保持冻存细胞活性的干细胞凝胶制剂及其应用 | |
CN106982821A (zh) | 脐带间充质干细胞临床冻存保护液组合物及其用途 | |
CN102511471B (zh) | 一种间充质干细胞冻存液及其制备方法 | |
CN101919380B (zh) | 一种改进的间充质干细胞保护液及其用途 | |
CN103404509B (zh) | 一种细胞保存液、其制备方法和应用 | |
CN103583511B (zh) | 一种间充质干细胞冻存液及注射液 | |
CN104928229B (zh) | 一种铁皮石斛干细胞冻干粉的制备方法及其用途 | |
CN102660497A (zh) | 脐带组织冻存、复苏以及分离和扩增干细胞的方法 | |
CN107467014A (zh) | 一种脐带组织冻存、复苏的方法 | |
CN104542578A (zh) | 一种细胞保存液及其制备方法、应用 | |
CN103070161A (zh) | 一种脂肪间充质干细胞冻存液及冻存方法 | |
CN104873542A (zh) | 一种脐带间充质干细胞注射液及其制备方法和应用 | |
CN105920042A (zh) | 具有抗衰老功效的脐带间充质干细胞注射液及其制备方法 | |
CN108184819A (zh) | 一种人脐带华通氏胶组织的冻存保护液及其制备与应用 | |
CN101037666B (zh) | 一种动物细胞的低温保存溶液及保存方法 | |
CN102660503A (zh) | 从脐带中分离和扩增间充质干细胞的方法 | |
CN109846722A (zh) | 间充质干细胞冻干粉剂及其制备方法 | |
CN109464463A (zh) | 间充质干细胞外泌体抗皮肤表皮细胞氧化的特性及其制剂的制备方法 | |
CN110367242A (zh) | 凋亡小体保存液及凋亡小体的保存方法 | |
KR20150039263A (ko) | 천연 식물 발효 추출물 및 해양 유래 물질을 함유하는 화장료 조성물 | |
CN102365933A (zh) | 一种间充质干细胞保存液及其制备方法与应用 | |
Mito et al. | Hepatocellular transplantation: morphological study on hepatocytes transplanted into rat spleen | |
CN113973805B (zh) | 细胞冻存试剂盒及其使用方法 | |
CN105494315A (zh) | 活细胞产品保存液及其制备、使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200131 Address after: 100032 Beijing city Xicheng District Xishiku Street No. 31 Building No. 23 hospital Applicant after: Beijing tangyihuikang Biomedical Technology Co.,Ltd. Address before: 100032 Beijing city Xicheng District Xishiku Street No. 31 Building No. 23 hospital Applicant before: BEIJING ZHEN HUIKANG BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20180601 Assignee: Tang Yi Huikang (Shenzhen) Biomedical Technology Co.,Ltd. Assignor: Beijing tangyihuikang Biomedical Technology Co.,Ltd. Contract record no.: X2024980005923 Denomination of invention: An improved mesenchymal stem cell protective solution and its application Granted publication date: 20210115 License type: Common License Record date: 20240517 |